133 related articles for article (PubMed ID: 35731051)
21. The Genomics and Molecular Biology of Natural Killer/T-Cell Lymphoma: Opportunities for Translation.
de Mel S; Soon GS; Mok Y; Chung TH; Jeyasekharan AD; Chng WJ; Ng SB
Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29966370
[TBL] [Abstract][Full Text] [Related]
22. [Incidence and treatment of extranodal natural killer/T-cell lymphoma nasal type. Hungarian experiences].
Bakos A; Szomor Á; Schneider T; Miltényi Z; Marton I; Borbényi Z; Pammer J; Krenács L; Bagdi E; Piukovics K
Orv Hetil; 2017 Oct; 158(41):1635-1641. PubMed ID: 29025287
[TBL] [Abstract][Full Text] [Related]
23. Epstein-Barr virus-negative extranodal "true" natural killer-cell lymphoma harbouring a KDM6A mutation.
Tsuyama N; Asaka R; Dobashi A; Baba S; Mishima Y; Ueda K; Oguchi M; Tsuji H; Hatake K; Takeuchi K
Hematol Oncol; 2018 Feb; 36(1):328-335. PubMed ID: 28695659
[TBL] [Abstract][Full Text] [Related]
24. The identification of gene signatures in patients with extranodal NK/T-cell lymphoma from a pair of twins.
Wang Y; Tan H; Yu T; Ma X; Chen X; Jing F; Zou L; Shi H
BMC Cancer; 2021 Dec; 21(1):1303. PubMed ID: 34872521
[TBL] [Abstract][Full Text] [Related]
25. Nasal-type extranodal natural killer/T-cell lymphoma presenting with a mass on the buttock: A case report.
Liu S; Zhou X; Song A; Huo Z; Wang Y; Liu Y
Medicine (Baltimore); 2019 Dec; 98(49):e18260. PubMed ID: 31804361
[TBL] [Abstract][Full Text] [Related]
26. Frequent structural variations involving programmed death ligands in Epstein-Barr virus-associated lymphomas.
Kataoka K; Miyoshi H; Sakata S; Dobashi A; Couronné L; Kogure Y; Sato Y; Nishida K; Gion Y; Shiraishi Y; Tanaka H; Chiba K; Watatani Y; Kakiuchi N; Shiozawa Y; Yoshizato T; Yoshida K; Makishima H; Sanada M; Onozawa M; Teshima T; Yoshiki Y; Ishida T; Suzuki K; Shimada K; Tomita A; Kato M; Ota Y; Izutsu K; Demachi-Okamura A; Akatsuka Y; Miyano S; Yoshino T; Gaulard P; Hermine O; Takeuchi K; Ohshima K; Ogawa S
Leukemia; 2019 Jul; 33(7):1687-1699. PubMed ID: 30683910
[TBL] [Abstract][Full Text] [Related]
27. Avelumab for the treatment of relapsed or refractory extranodal NK/T-cell lymphoma: an open-label phase 2 study.
Kim SJ; Lim JQ; Laurensia Y; Cho J; Yoon SE; Lee JY; Ryu KJ; Ko YH; Koh Y; Cho D; Lim ST; Enemark MB; D'Amore F; Bjerre M; Ong CK; Kim WS
Blood; 2020 Dec; 136(24):2754-2763. PubMed ID: 32766875
[TBL] [Abstract][Full Text] [Related]
28. A comparative population-based analysis of sinonasal diffuse large B-cell and extranodal NK/T-cell lymphomas.
Dubal PM; Dutta R; Vazquez A; Patel TD; Baredes S; Eloy JA
Laryngoscope; 2015 May; 125(5):1077-83. PubMed ID: 25546466
[TBL] [Abstract][Full Text] [Related]
29. Toxic epidermal necrolysis associated with chemoimmunotherapy for lymphoma: case report and literature review.
Yang W; Xu X; Xia D; Wang H; Jiang J; Yang G
Immunotherapy; 2022 Apr; 14(5):275-282. PubMed ID: 35128931
[TBL] [Abstract][Full Text] [Related]
30. High IL-6 expression in the tumor microenvironment is associated with poor prognosis of patients with extranodal natural / killer T-cell lymphoma (ENKTL).
Rong Q; Gao Y; Cai Q; Wang X; Bai B; Ping L; He H; Rao H; Zhang Y; Li Z; Cai Q; Jiang W; Huang H
Expert Rev Anticancer Ther; 2021 Jan; 21(1):121-127. PubMed ID: 33397158
[No Abstract] [Full Text] [Related]
31. Extranodal NK/T cell lymphoma.
Jeong SH
Blood Res; 2020 Jul; 55(S1):S63-S71. PubMed ID: 32719179
[TBL] [Abstract][Full Text] [Related]
32. PD-L1 is upregulated by EBV-driven LMP1 through NF-κB pathway and correlates with poor prognosis in natural killer/T-cell lymphoma.
Bi XW; Wang H; Zhang WW; Wang JH; Liu WJ; Xia ZJ; Huang HQ; Jiang WQ; Zhang YJ; Wang L
J Hematol Oncol; 2016 Oct; 9(1):109. PubMed ID: 27737703
[TBL] [Abstract][Full Text] [Related]
33. Expression of programmed death-1 in cutaneous extranodal natural killer/T-cell lymphoma and its effect on clinical findings and biological behaviour.
Kim YJ; Won CH; Chang SE; Lee MW; Choi JH; Lee WJ
J Eur Acad Dermatol Venereol; 2017 May; 31(5):821-827. PubMed ID: 28190256
[TBL] [Abstract][Full Text] [Related]
34. Extranodal nasal-type natural killer/T-cell lymphoma with penile involvement: a case report and review of the literature.
Wang X; Gong Z; Li SX; Yan W; Song Y
BMC Urol; 2017 Sep; 17(1):77. PubMed ID: 28874193
[TBL] [Abstract][Full Text] [Related]
35. Extranodal NK/T-cell lymphoma, nasal type: report of 15 cases.
Tababi S; Kharrat S; Sellami M; Mamy J; Zainine R; Beltaief N; Sahtout S; Besbes G
Eur Ann Otorhinolaryngol Head Neck Dis; 2012 Jun; 129(3):141-7. PubMed ID: 22321911
[TBL] [Abstract][Full Text] [Related]
36. Survival outcomes of patients with extranodal natural-killer T-cell lymphoma: a prospective cohort study from the international T-cell Project.
Fox CP; Civallero M; Ko YH; Manni M; Skrypets T; Pileri S; Kim SJ; Cabrera ME; Shustov AR; Chiattone CS; Horwitz SM; Dlouhy I; Spina M; Hitz F; Montoto S; Nagler A; Martinez V; De Souza CA; Fernandez-Alvarez R; Ballova V; Gabús R; Inghirami G; Federico M; Kim WS
Lancet Haematol; 2020 Apr; 7(4):e284-e294. PubMed ID: 32105608
[TBL] [Abstract][Full Text] [Related]
37. [Clinicopathologic analysis of extranodal non-hodgkin lymphoma of the sinonasal cavities: a 15-case report].
Zhang YH; Duan QC; Zuo Q; Du C; Xie LF; Zhu L
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Nov; 31(21):1653-1657. PubMed ID: 29798121
[No Abstract] [Full Text] [Related]
38. Cutaneous extranodal natural killer/T-cell lymphoma: a comparative clinicohistopathologic and survival outcome analysis of 45 cases according to the primary tumor site.
Lee WJ; Jung JM; Won CH; Chang SE; Choi JH; Chan Moon K; Park CS; Huh J; Lee MW
J Am Acad Dermatol; 2014 Jun; 70(6):1002-9. PubMed ID: 24629518
[TBL] [Abstract][Full Text] [Related]
39. Extranodal natural killer/T-cell lymphoma invading a patient's heart: A rare case report and literature review.
Xiang Y; Lin X; Cai X; Qu S; Lin KY
Front Oncol; 2022; 12():1011894. PubMed ID: 36568165
[TBL] [Abstract][Full Text] [Related]
40. [The Application Value of True Whole-body PET/CT Scanning Protocol in Patients of Extranodal NK/T Cell Lymphoma].
Li FL; Su MG; Shi DZ; Liang FL; Li L
Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 Mar; 51(2):245-251. PubMed ID: 32220195
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
